<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28335">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01798316</url>
  </required_header>
  <id_info>
    <org_study_id>12-0409</org_study_id>
    <secondary_id>IRB #12-409B</secondary_id>
    <nct_id>NCT01798316</nct_id>
  </id_info>
  <brief_title>IV Acetaminophen for Postoperative Analgesia</brief_title>
  <official_title>IV Acetaminophen for Postoperative Analgesia After Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Shore Long Island Jewish Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Shore Long Island Jewish Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use of IV acetaminophen for postoperative pain
      management after laparoscopic cholecystectomy, to determine if its use decreases the
      incidence of post-operative nausea and vomiting without compromising pain control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The recent clinical development of an intravenous (IV) acetaminophen formulation for use in
      the US has important implications for the management of postoperative pain given its safety
      profile and suitability for use in the early phase of the postoperative period. In clinical
      studies, a significant opioid-sparing effect has been documented with a substantial
      percentage of patients avoiding the need for opioid rescue medication altogether. This
      avoidance or delay in the use of opioids has been shown to reduce undesirable side effects.
      It is proposed that the use of IV acetaminophen as 1st line analgesic regimen in the post
      anesthesia care unit (PACU) for postoperative analgesia after laparoscopic cholecystectomy
      will result in decreased incidence of post operative nausea and vomiting (PONV) without
      compromising patient pain control and satisfaction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Incidence of postoperative nausea and vomiting (PONV) during PACU stay</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Incidence of PONV will be recorded during PACU stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PONV severity during PACU stay</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain scores on  verbal rating scale and visual analog scale</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Time to rescue medication</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Rescue medication dosage</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction on a 5 point Likert scale</measure>
    <time_frame>3 days post surgery</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">224</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Nausea</condition>
  <condition>Postoperative Vomiting</condition>
  <arm_group>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV Acetaminophen administered on admission to PACU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care pain management regimen including opioids administered on admission to PACU</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Acetaminophen</intervention_name>
    <description>Single dose, 1000g mg infusion over 15 minutes</description>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <other_name>Ofirmev</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Morphine 5mg every 10 min for 2 doses</description>
    <arm_group_label>Standard of care</arm_group_label>
    <other_name>As per provider: Opioids</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is undergoing pre-scheduled laparoscopic cholecystectomy;

          -  American Society of Anesthesiology patient classification status I-II

        Exclusion Criteria:

          -  Regular preoperative use of or opioids,

          -  Subjects admitted after surgery for postoperative  complications other than
             postoperative pain or PONV.

          -  Subjects converted to open laparoscopic cholecystectomy

          -  Known allergy/hypersensitivity to acetaminophen

          -  Use of opioids prior to commencement of the study (&lt;7 days)

          -  Patients  with chronic pain conditions or disease requiring pain control

          -  Abnormal liver function

          -  Known or suspected alcohol, drug or opiate abuse or dependence

          -  Patients with a BMI of greater than 35

          -  Other physical, mental or medical conditions that could effect participation.

          -  Abnormal renal function; serum creatinine&gt;2gm/dl
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank J Overdyk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore LIJ Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frank J Overdyk, MD</last_name>
    <phone>718-470-7630</phone>
    <email>foverdyk@nshs.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Campese, MD</last_name>
      <phone>516-562-4887</phone>
      <email>ccampse@nshs.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Campse, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis Macchio, MD</last_name>
      <phone>718-470-7630</phone>
      <email>fmacchio@nshs.edu</email>
    </contact>
    <investigator>
      <last_name>Francis J Macchio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Syosset Hospital</name>
      <address>
        <city>Syosset</city>
        <state>New York</state>
        <zip>11791</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fredric Fabiano, MD</last_name>
      <phone>516-496-6427</phone>
      <email>ffabiano@nshs.edu</email>
    </contact>
    <investigator>
      <last_name>Fredric Fabiano, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>February 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Shore Long Island Jewish Health System</investigator_affiliation>
    <investigator_full_name>Frank Overdyk</investigator_full_name>
    <investigator_title>Executive Director for Research - Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>IV Acetaminophen</keyword>
  <keyword>Laparoscopic cholecystectomy</keyword>
  <keyword>Postoperative nausea</keyword>
  <keyword>Postoperative vomiting</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
